About Rokshaw
Rokshaw is a company based in Sunderland (United Kingdom) founded in 2012 was acquired by Emmac in April 2019.. Rokshaw has raised $460.1 thousand across 1 funding round from investors including Emmac and North East Fund. Rokshaw offers products and services including Drug Tariff Specials, Non-Tariff Specials, Special Obtains, and Imports. Rokshaw operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others.
- Headquarter Sunderland, United Kingdom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Thistle Pharma Ltd
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rokshaw
Rokshaw offers a comprehensive portfolio of products and services, including Drug Tariff Specials, Non-Tariff Specials, Special Obtains, and Imports. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Manufactured unlicensed medicines for tariff-listed needs.
Custom formulations not on standard tariffs.
Sourced and supplied specific unlicensed products.
Imported unlicensed medicines for UK market.
Funding Insights of Rokshaw
Rokshaw has successfully raised a total of $460.1K through 1 strategic funding round. The most recent funding activity was a Seed round of $460.1 thousand completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $460,100
-
First Round
First Round
(26 Sep 2018)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2018 | Amount | Seed - Rokshaw | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Rokshaw
Rokshaw has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Emmac and North East Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment finance is provided to small and medium-sized enterprises.
|
Founded Year | Domain | Location | |
|
Medical cannabis products are produced and supplied by Emmac.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rokshaw
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rokshaw
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rokshaw Comparisons
Competitors of Rokshaw
Rokshaw operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Recipharm, Unither and Nectar Lifesciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| domain | founded_year | HQ Location |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| domain | founded_year | HQ Location |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| domain | founded_year | HQ Location |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| domain | founded_year | HQ Location |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| domain | founded_year | HQ Location |
CDMO with a focus on early phase drug product development
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Rokshaw
When was Rokshaw founded?
Rokshaw was founded in 2012 and raised its 1st funding round 6 years after it was founded.
Where is Rokshaw located?
Rokshaw is headquartered in Sunderland, United Kingdom. It is registered at Sunderland, England, United Kingdom.
Is Rokshaw a funded company?
Rokshaw is a funded company, having raised a total of $460.1K across 1 funding round to date. The company's 1st funding round was a Seed of $460.1K, raised on Sep 26, 2018.
What does Rokshaw do?
Rokshaw was founded in 2012 in Sunderland, United Kingdom, as a manufacturer and supplier in the pharmaceutical sector. External dosage forms such as creams, ointments, soaps, ear drops, nasal drops, enema solutions, pessaries, paints, gels, pastes, and lotions are produced. Additional products include solutions, suspensions, lozenges, medicated lollipops, reefer packs, capsules, oral syringes, suppositories, and sachets. Services are extended to hospitals, wholesalers, pharmacies, and dispensing doctors throughout the UK.
Who are the top competitors of Rokshaw?
Rokshaw's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
What products or services does Rokshaw offer?
Rokshaw offers Drug Tariff Specials, Non-Tariff Specials, Special Obtains, and Imports.
Who are Rokshaw's investors?
Rokshaw has 2 investors. Key investors include Emmac, and North East Fund.